por John R. Fischer
, Senior Reporter | February 18, 2021
Healthcare providers operating in 40 U.S. states have banded together to form Truveta, a new company that will utilize each one’s individual data to design a platform that provides insights on how to better care for patients through machine learning and AI.
The platform is expected to support the development of new therapies and deliver valuable insights from billions of clinical data points in a single search. The purpose is for the providers to learn from one another’s de-identified data and improve their performance.
“We want to help researchers find cures faster, empower every clinician to be an expert, and help families make the most informed decisions on their care. We believe the Truveta platform can help improve health equity and advance personalized medicine,” said Terry Myerson, CEO of Truveta, in a statement.
The right combination of workflow, clinical equipment and technology can improve patient care, clinical outcomes and your bottom line. Click above to learn more.
The 14 providers involved include AdventHealth, Advocate Aurora Health, Baptist Health of Northeast Florida, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, Henry Ford Health System, Memorial Hermann Health System, Northwell Health, Novant Health, Providence health system, Sentara Healthcare, Tenet Health, and Trinity Health. All will provide structured, normalized and de-identified data to form the platform. It will also take into account patient privacy and security.
The platform will use AI and machine learning to structure and normalize both structured and unstructured data types across all diagnoses, geographies and demographics, and aggregate analyses of conditions, therapies, and prognoses to continuously teach physicians, researchers, biopharmacists and other healthcare professionals.
The catalyst behind Truveta’s formation is the COVID-19 pandemic, with the providers asserting that had it been designed earlier, the platform could have potentially saved thousands of lives. They say that it could have been used to recruit statistically representative populations in clinical trials, which would have shortened the vaccine approval process, and to provide a greater understanding of health equity to ensure equitable distribution of vaccines.
“We in health care exist side-by-side in our communities and we need to prioritize cooperation to truly make a difference — now, more than we ever have,” said Lloyd Dean, CEO of CommonSpirit Health. “We have a unique opportunity today to rebuild the healthcare system in our country, so it is better, stronger, and more responsive to the needs of everyone, especially the vulnerable and underserved populations.”
Providers, and education and research institutions worldwide are welcome to contribute to the development of the Truveta platform. A board of governors will advise the company to ensure it is consulting with diverse expertise. The providers will govern the platform’s ethical pursuit of insights from this unprecedented de-identified data set.